AstraZeneca | Fortune

Skip to Content

SIGN IN

Newsletters
Global stocks fall, dollar rises as stimulus talks fade and COVID cases spike
By
Bernhard Warner
October 26, 2020
Health
AstraZeneca cleared by U.S. regulators to resume COVID vaccine trial
By
Bloomberg
October 23, 2020
Health
Participant who died in AstraZeneca trial had not been given vaccine
By
Timothy Annett,
Walter Brandimarte,
and others
October 22, 2020
Health
As COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination
By
David Meyer
October 15, 2020
Health
A Pelosi snub and a giant federal COVID grant: Another dizzying day in Washington for the U.K.’s AstraZeneca
By
Jeremy Kahn
October 12, 2020
Health
Which COVID-19 vaccine works best? A new lab network promises an answer
By
Jeremy Kahn
October 6, 2020
Health
With AstraZeneca’s COVID-19 vaccine trials on hold in the U.S., a gulf widens between America and other countries
By
Jeremy Kahn
October 2, 2020
Health
Under fire, AstraZeneca CEO defends transparency of COVID-19 vaccine trials
By
Jeremy Kahn
September 24, 2020
International
To jumpstart the COVID vaccine race, the U.K. considers ‘challenge trials’ exposing people to the virus
By
James Paton
and
Bloomberg
September 24, 2020
Magazine
‘The whole world is coming together’: How the race for a COVID vaccine is revolutionizing Big Pharma
By
Clifton Leaf
September 21, 2020
Health
China’s Sinovac plans to test COVID vaccine on children before the company is sure the inoculation works in adults
By
Grady McGregor
and
Jeremy Kahn
September 18, 2020
International
AstraZeneca’s COVID-19 vaccine is back on track after getting the green light to resume trials in the U.K.
By
Stephanie Baker
and
Bloomberg
September 13, 2020
Newsletters
The rollercoaster of COVID-19 vaccines
By
Sy Mukherjee
September 10, 2020
Health
COVID-19 vaccine still on track for later this year despite trial pause, AstraZeneca CEO says
By
Jeremy Kahn
September 10, 2020

1 - 14 of 53 results

1 - 14 of 53 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.